Molecular mechanisms of action of bisphosphonates and new insights into their effects outside the skeleton

MJ Rogers, J Mönkkönen, MA Munoz - Bone, 2020 - Elsevier
Bisphosphonates (BP) are a class of calcium-binding drug used to prevent bone resorption
in skeletal disorders such as osteoporosis and metastatic bone disease. They act by …

Insights and implications of sexual dimorphism in osteoporosis

YY Zhang, N Xie, XD Sun, EC Nice, YC Liou, C Huang… - Bone research, 2024 - nature.com
Osteoporosis, a metabolic bone disease characterized by low bone mineral density and
deterioration of bone microarchitecture, has led to a high risk of fatal osteoporotic fractures …

[HTML][HTML] Bone function, dysfunction and its role in diseases including critical illness

N Su, J Yang, Y Xie, X Du, H Chen… - International journal of …, 2019 - ncbi.nlm.nih.gov
The skeleton is one of the largest organs in the human body. In addition to its conventional
functions such as support, movement and protection, the skeleton also contributes to whole …

Effects of zoledronate on cancer, cardiac events, and mortality in osteopenic older women

IR Reid, AM Horne, B Mihov, A Stewart… - Journal of Bone and …, 2020 - academic.oup.com
We recently showed that zoledronate prevented fractures in older women with osteopenia
(hip T‐scores between− 1.0 and− 2.5). In addition to fewer fractures, this study also …

Association between drug treatments for patients with osteoporosis and overall mortality rates: a meta-analysis

SR Cummings, LY Lui, R Eastell… - JAMA internal medicine, 2019 - jamanetwork.com
Importance Previous studies have reported that drug treatments, particularly treatment with
bisphosphonates, is associated with reduced overall mortality rates in addition to decreased …

The interplay of drug therapeutics and immune responses to SARS-CoV-2

V Fumagalli, M Iannacone - Cellular & Molecular Immunology, 2024 - nature.com
The SARS-CoV-2 pandemic has necessitated rapid therapeutic and preventative responses.
While vaccines form the frontline of defense, antiviral treatments such as nirmatrelvir have …

Association between bisphosphonate use and COVID-19 related outcomes

J Thompson, Y Wang, T Dreischulte, O Barreiro… - Elife, 2023 - elifesciences.org
Background: Although there are several efficacious vaccines against COVID-19, vaccination
rates in many regions around the world remain insufficient to prevent continued high …

Vitamin D and critical illness: what endocrinology can learn from intensive care and vice versa

K Amrein, A Papinutti, E Mathew, G Vila… - Endocrine …, 2018 - ec.bioscientifica.com
The prevalence of vitamin D deficiency in intensive care units ranges typically between 40
and 70%. There are many reasons for being or becoming deficient in the ICU. Hepatic …

Bisphosphonates and lifespan

JR Center, KW Lyles, D Bliuc - Bone, 2020 - Elsevier
Bisphosphonates are first line agents used to treat osteoporosis and reduce fracture rate.
They bind to areas of exposed calcium in the skeleton and cause osteoclast apoptosis …

An update of the effects of vitamins D and C in critical illness

A Hill, C Starchl, E Dresen, C Stoppe… - Frontiers in Medicine, 2023 - frontiersin.org
Many critically ill patients are vitamin D and vitamin C deficient and the current international
guidelines state that hypovitaminoses should be compensated. However, uncertainty about …